Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,500,000
-
Total 13F shares
-
53,169,400
-
Share change
-
-112,310
-
Total reported value
-
$5,962,973,942
-
Put/Call ratio
-
272%
-
Price per share
-
$112.15
-
Number of holders
-
265
-
Value change
-
+$30,620,547
-
Number of buys
-
127
-
Number of sells
-
128
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2020
As of 31 Dec 2020,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
265 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,169,400 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, LONE PINE CAPITAL LLC, STATE STREET CORP, Casdin Capital, LLC, JPMORGAN CHASE & CO, Invesco Ltd., ALLIANCEBERNSTEIN L.P., and HILLHOUSE CAPITAL ADVISORS, LTD..
This page lists
267
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.